Judith Campbell
8Patents
3h-index
8Co-inventors
50Inventor score
Filing activity: Feb 14, 1994 → Oct 29, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5843703A | Enhanced production of toxic polypeptides in prokaryotes | Chemistry; Metallurgy | 6 | Expired |
| US6255062A | .beta.-type DNA polymerases | Human Necessities | 4 | Expired |
| US9932310B2 | DNA2 inhibitors for cancer treatment | Human Necessities | 4 | Active |
| US10173984B2 | DNA2 inhibitors for cancer treatment | Human Necessities | 3 | Active |
| US10562856B2 | DNA2 inhibitors for cancer treatment | Human Necessities | 2 | Active |
| US11198675B2 | DNA2 inhibitors for cancer treatment | Human Necessities | 1 | Active |
| US9322022B2 | Inhibition of DNA2 in fanconi anemia | Chemistry; Metallurgy | 0 | Active |
| US11780815B2 | DNA2 inhibitors for cancer treatment | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.